Royalty Pharma (RPRX) PT Raised to $51 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 65.99 -0.41 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.40 | 52 Week High | $3.48 | |||
| Open | $65.65 | 52 Week Low | $0.80 | |||
| Day High | $67.18 | P/E | N/A | |||
| Day Low | $64.84 | EPS | $-1.54 | |||
| Volume | 1,080,099 | |||||
